Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 15, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-04
DOI
10.3389/fnins.2021.690013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases
- (2020) Giovanni Palermo et al. MOLECULAR NEUROBIOLOGY
- NfL as a biomarker for neurodegeneration and survival in Parkinson disease
- (2020) David Bäckström et al. NEUROLOGY
- The role of synaptic biomarkers in the spectrum of neurodegenerative diseases
- (2020) Sonia Mazzucchi et al. Expert Review of Proteomics
- Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism
- (2020) Nahid Tayebi et al. TRENDS IN MOLECULAR MEDICINE
- The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development
- (2019) Filippo Baldacci et al. Expert Review of Proteomics
- Parkinson’s disease biomarkers based on α‐synuclein
- (2019) Muneera Fayyad et al. JOURNAL OF NEUROCHEMISTRY
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Parkinson disease
- (2019) R. Balestrino et al. EUROPEAN JOURNAL OF NEUROLOGY
- CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls
- (2019) Linda P. Oosterveld et al. MOVEMENT DISORDERS
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Nigrostriatal dopamine transporter availability in early Parkinson's disease
- (2018) Patrik Fazio et al. MOVEMENT DISORDERS
- Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
- (2018) Joery Goossens et al. Alzheimers Research & Therapy
- CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
- (2018) Peter Körtvelyessy et al. Frontiers in Neurology
- Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration
- (2018) Jian-Zhi Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
- (2018) Bob Olsson et al. JAMA Neurology
- Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease
- (2017) Lucia Farotti et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2017) Maxim De Schaepdryver et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Progranulin, lysosomal regulation and neurodegenerative disease
- (2017) Aimee W. Kao et al. NATURE REVIEWS NEUROSCIENCE
- Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
- (2017) Emily Feneberg et al. NEUROLOGY
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
- (2016) Sara Hall et al. MOVEMENT DISORDERS
- Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia
- (2016) Carlo Wilke et al. Neurodegenerative Diseases
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
- (2015) Patrick Weydt et al. ANNALS OF NEUROLOGY
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- (2015) N K Magdalinou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
- (2013) Nin Bajaj et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?
- (2013) Gordon W. Duncan et al. MOVEMENT DISORDERS
- Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease
- (2013) Karin D. van Dijk et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers in Parkinson disease
- (2013) Lucilla Parnetti et al. Nature Reviews Neurology
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- 123I-FP-Cit and 123I-IBZM SPECT uptake in a prospective normal material analysed with two different semiquantitative image evaluation tools
- (2013) Susanna Jakobson Mo et al. NUCLEAR MEDICINE COMMUNICATIONS
- Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease
- (2013) Karin D. van Dijk et al. PARKINSONISM & RELATED DISORDERS
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Alterations in axonal transport motor proteins in sporadic and experimental Parkinson’s disease
- (2012) Yaping Chu et al. BRAIN
- Putamen neurons process both sensory and motor information during a complex task
- (2012) Ana F. Vicente et al. BRAIN RESEARCH
- The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration
- (2011) J. L. Cummings et al. BRAIN
- Neurochemical biomarkers in the differential diagnosis of movement disorders
- (2009) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Molecular mechanisms of α-synuclein neurodegeneration
- (2008) Elisa A. Waxman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Second consensus statement on the diagnosis of multiple system atrophy
- (2008) S. Gilman et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started